Clinical Trials · NCT06778967
A Phase III Clinical Study to Evaluate the Efficacy and Safety of GZR18 Injection in Adult Type 2 Diabetes Mellitus
- Phase
- Phase 3
- Recruitment status
- Active Not Recruiting
- Sponsor
- Gan & Lee Pharmaceuticals.
- Enrollment
- 1,100
- Start date
- Feb 2025
- Locations
- 1 site, China
- Primary endpoint
- Change from Baseline in Hemoglobin A1c (HbA1c)(%)